Amanote Research

Amanote Research

    RegisterSign In

Drug Treatment of Heart Failure

Drugs - United Kingdom
doi 10.2165/00003495-199000394-00006
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

January 1, 1990

Authors
Philip A. Poole-Wilson
Publisher

Springer Science and Business Media LLC


Related search

Gold Nanoparticles: Challenge of PPPM for Heart Failure Treatment and Drug Delivery

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2014English

Potential Drug-Drug Interactions in Heart Failure Patients

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Treatment of Patients With Heart Failure.

Circulation
Cardiovascular MedicinePhysiologyCardiology
1990English

Early Diagnosis and Treatment of Heart Failure

BMJ
1937English

Heart Rate as a Target of Treatment of Chronic Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2012English

Treatment Strategies for the Prevention of Heart Failure

Current Heart Failure Reports
Emergency MedicineCardiovascular MedicinePhysiologyCardiology
2013English

Ivabradine: Current and Future Treatment of Heart Failure

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Treatment of Terminal Heart Failure in Grown Up Congenital Heart Disease.

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Heart Failure After Treatment for Breast Cancer

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy